XML 88 R36.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Organization and Principal Activities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Significant Operating Subsidiaries | As of December 31, 2023, the Company’s significant operating subsidiaries were as follows:
Name of Company |  | Place of Incorporation |  | Date of Incorporation |  | Percentage of Ownership |  | Principal Activities
Zai Lab (Hong Kong) Limited |  | Hong Kong |  | April 29, 2013 |  | 100% |  | Operating company for business development and R&D activities and commercialization of innovative medicines and device
Zai Lab (Shanghai) Co., Ltd. |  | Mainland China |  | January 6, 2014 |  | 100% |  | Development and commercialization of innovative medicines and devices
Zai Lab (AUST) Pty. Ltd. |  | Australia |  | December 10, 2014 |  | 100% |  | Clinical trial activities
Zai Lab (Suzhou) Co., Ltd. |  | Mainland China |  | November 30, 2015 |  | 100% |  | Development and commercialization of innovative medicines
Zai Biopharmaceutical (Suzhou) Co., Ltd. |  | Mainland China |  | June 15, 2017 |  | 100% |  | Development and commercialization of innovative medicines
Zai Lab (US) LLC |  | United States |  | April 21, 2017 |  | 100% |  | Operating company for business development, R&D activities and certain business activities, including legal, compliance and communication functions of the Company
Zai Lab International Trading (Shanghai) Co., Ltd. |  | Mainland China |  | November 6, 2019 |  | 100% |  | Commercialization of innovative medicines and devices
Zai Auto Immune (Hong Kong) Limited |  | Hong Kong |  | November 4, 2020 |  | 100% |  | Operating company for business development and R&D activities
Zai Lab (Taiwan) Limited |  | Taiwan |  | December 10, 2020 |  | 100% |  | Commercialization of innovative medicines and devices
Zai Lab Trading (Suzhou) Co., Ltd. |  | Mainland China |  | October 27, 2020 |  | 100% |  | Commercialization of innovative medicines and devices

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration